Listing 1 - 3 of 3 |
Sort by
|
Choose an application
Avant-propos - Synthèse - 1. Objectifs stratégiques et population cible - 2. Le contexte ... Venir en aide aux plus vulnérables - 3. Mesures proposées par domaine d'action - 4. Timing de la mise en œuvre, du suivi et de l'évaluation - 5. Analyse de l'impact budgétaire - 6. Annexes
Choose an application
1. Généralités - 2. Aspects médicaux des maladies rares - 3. Aspects psychosociaux : les maladies rares sur le terrain et au quotidien - 4. Recherche dans les maladies rares - 5. Prévention des maladies rares - 6. Guidelines - 7. Conclusions
Rare Diseases --- Maladies rares --- diagnosis --- Diagnostic. --- Rare Diseases. --- Rare diseases --- Maladies rares. --- Ziekten en aandoeningen (niet-HRM) : Zeldzame aandoeningen --- Maladies et affections (non GRH) : Affections rares --- diagnosis.
Choose an application
This authoritative and comprehensive book makes the reader familiar with the processes of bringing orphan drugs to the global market. There are between 5,000 and 7,000 rare diseases and the number of patients suffering from them is estimated to be more than 50 million in the US and Europe. Before the orphan drug legislation enacted in the US in 1983, there was a limited interest from industry to develop treatment for very small patient groups. One of the difficulties is, of course, that similar levels of investment are needed from a pharmaceutical company to bring a drug to the market for both
Orphan Drug Production -- periodicals. --- Orphan drugs --- Drug approval --- Drug and Narcotic Control --- Evaluation Studies as Topic --- Drug Industry --- Industry --- Legislation, Drug --- Investigative Techniques --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Social Control, Formal --- Technology, Industry, and Agriculture --- Sociology --- Technology, Industry, Agriculture --- Social Sciences --- Anthropology, Education, Sociology and Social Phenomena --- Orphan Drug Production --- Drug Approval --- Health & Biological Sciences --- Business & Economics --- Industries --- Pharmacy, Therapeutics, & Pharmacology --- Law and legislation --- Orphan drugs. --- Drugs of limited commercial value --- Nonprofitable drugs --- Drugs --- Ziekten en aandoeningen (niet-HRM) : Zeldzame aandoeningen --- Maladies et affections (non GRH) : Affections rares
Listing 1 - 3 of 3 |
Sort by
|